Zobrazeno 1 - 10
of 185
pro vyhledávání: '"Kun-Ming Rau"'
Autor:
Tsung-Hao Liu, San-Chi Chen, Kun-Ming Rau, Li-Chun Lu, Po-Ting Lin, Yung-Yeh Su, Wei Teng, Shiue-Wei Lai, Ren-Hua Yeh, Tsui-Mai Kao, Pei-Chang Lee, Chi-Jung Wu, Chien-Hung Chen, Chih-Hung Hsu, Shi-Ming Lin, Yi-Hsiang Huang, Li-Tzong Chen, Ann-Lii Cheng, Ying-Chun Shen
Publikováno v:
Liver Cancer (2024)
Introduction The progression patterns, dispositions, and outcomes of patients with advanced hepatocellular carcinoma (HCC) who achieved durable responses with immunotherapy remain poorly characterized. Methods Patients with advanced HCC who received
Externí odkaz:
https://doaj.org/article/982567d91e37462383001cc9dc3d4719
Autor:
Masatoshi Kudo, Richard S. Finn, Manabu Morimoto, Kun-Ming Rau, Masafumi Ikeda, Chia-Jui Yen, Peter R. Galle, Josep M. Llovet, Bruno Daniele, Ho Yeong Lim, David W. McIlwain, Reigetsu Yoshikawa, Kenichi Nakamura, Kun Liang, Chunxiao Wang, Paolo Abada, Ryan C. Widau, Andrew X. Zhu
Publikováno v:
Liver Cancer, Pp 1-10 (2021)
Background: Intermediate-stage hepatocellular carcinoma (HCC), as defined by Barcelona Clinic Liver Cancer (BCLC) stage B, is heterogeneous in terms of liver function and tumor burden. REACH and REACH-2 investigated ramucirumab in patients with HCC a
Externí odkaz:
https://doaj.org/article/45c831adde1a42d0a4519ec7cc5d2877
Autor:
Meng-Che Hsieh, Kun-Ming Rau, Shung-Eing Lin, Kuang-Wen Liu, Chong-Chi Chiu, Chih-I Chen, Ling-Chiao Song, Hsin-Pao Chen
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThere are no randomized control trials comparing the efficacy of trifluridine/tipiracil and regorafenib in patients with metastatic colorectal cancer (mCRC). Herein, we conducted an observational study to compare the oncologic outcomes of t
Externí odkaz:
https://doaj.org/article/76a6812e878e42ebbac1924348a089c4
Autor:
Hui-Ju Tsai, Ju-Chien Cheng, Man-Leng Kao, Hung-Pin Chiu, Yi-Hsuan Chiang, Ding-Ping Chen, Kun-Ming Rau, Hsiang-Ruei Liao, Ching-Ping Tseng
Publikováno v:
Cell & Bioscience, Vol 11, Iss 1, Pp 1-17 (2021)
Abstract Background Bidirectional integrin αIIbβ3 signaling is essential for platelet activation. The platelet adaptor protein Disabled-2 (Dab2) is a key regulator of integrin signaling and is phosphorylated at serine 24 in eukaryotic cells. Howeve
Externí odkaz:
https://doaj.org/article/5a1e6dd35ef346cba8f30b10bf7c7740
Autor:
Ping-I. Hsu, Seng-Kee Chuah, Jaw-Town Lin, Shen-Wen Huang, Jing-Chyuan Lo, Kun-Ming Rau, I-Shu Chen, Hui-Ya Hsu, Bor-Shyang Sheu, Wei-Kuo Chang, Deng-Chyang Wu
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 1, Pp 25-33 (2021)
Currently, consensus reports on the nutritional management for gastric cancer patients receiving gastric resection are lacking. The Gastroenterological Society of Taiwan therefore organized the Taiwan Gastric Cancer Nutritional Consensus Team to prov
Externí odkaz:
https://doaj.org/article/abcac29b77f04602897a43af5bbe3e12
Autor:
Pao-Yuan Huang, Kai-Lung Tsai, Chih-Ming Liang, Wei-Chen Tai, Kun-Ming Rau, Keng-Liang Wu, Chao-Cheng Huang, Seng-Kee Chuah
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 34, Iss 11, Pp 650-656 (2018)
There is an increasing trend in the incidence of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) worldwide. The aim of the present study was to identify the prognostic factors of patients with GEP-NENs. A cross-sectional, retrospective cha
Externí odkaz:
https://doaj.org/article/d4e8c065ec304aaeaec878e7e3a614e0
Autor:
Yun Zhang, Xin Li, Hongming Pan, Yoon-Koo Kang, Chia-Jui Yen, Ming-Mo Hou, Kun-Ming Rau, Ying Yuan, Xiaopeng Ma, Xikun Wu, Jong-Seok Lee, Cunjing Yu, Katie Wood
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/535c95318305473282560c0ef50dded5
Autor:
Bhumsuk Keam, Jayesh Desai, Ben Markman, Michael Millward, Yoon-Koo Kang, Chia-Chi Lin, Yee Chao, Sanjeev Deva, Jong Seok Lee, Chia-Jui Yen, Michael Jameson, Ming-Mo Hou, Chang-Hsien Lu, Kun-Ming Rau, Kyung-Hun Lee, Lisa Horvath, Michael Friedlander, Paula Barlow, Chi-Yuan Wu, Liang Liang, John Wu, Virginia Paton
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background The programmed cell death-1/programmed cell death ligand-1 (PD-1/PD-L1) axis plays a central role in suppressing antitumor immunity; axis dysregulation can be used by cancer cells to evade the immune system. Tislelizumab, an investigationa
Externí odkaz:
https://doaj.org/article/1f2f609e135d4807be9e954535daa4f0
Autor:
Sung-Nan Pei, Chun-Kai Liao, Yaw-Sen Chen, Cheng-Hao Tseng, Chao-Ming Hung, Chong-Chi Chiu, Meng-Che Hsieh, Yu-Fen Tsai, Hsiu-Yun Liao, Wei-Ching Liu, Kun-Ming Rau
Publikováno v:
Cancers, Vol 13, Iss 15, p 3831 (2021)
Background: Biliary tract cancer (BTC) is a heterogenous collection of biliary tract cancer at different primary sites, and the prognosis of advanced BTC is dismal. Systemic chemotherapy with gemcitabine and cisplatin (GC) has been the reference regi
Externí odkaz:
https://doaj.org/article/b5a96719942e4378ba827b06c97bfd6d
Autor:
Meng-Che Hsieh, Shih-Ho Wang, Ching-Ting Wei, Chung-Yen Chen, Yen-Yang Chen, Sung-Nan Pei, Yu-Fen Tsai, Kun-Ming Rau
Publikováno v:
Cancers, Vol 12, Iss 9, p 2384 (2020)
Background: Fluoropyrimidine- and platinum-based doublet regimen is the standard treatment of adjuvant chemotherapy (AC) for gastric cancer (GC). Our study aims to compare S1 with doublet regimens as AC in patients with advanced GC after radical surg
Externí odkaz:
https://doaj.org/article/70b11ec0d7d1450592004a57bac69c57